Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Market Access
No items found.
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.
Biomarkers
Chemical & Compound Analysis
Pharmacology
Novalix
Blog
Prof. Dr. Wagschal - What can we expect from the upcoming elections in Germany?
September 15, 2021
Read blog
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Health Economics & Outcomes Research (HEOR)
PicnicHealth
Blog
Transformative Antibody Technology Brings Speed and Flexibility to Bioanalytical Assay Development
September 13, 2021
Read blog
Antibodies
In Vitro Assays
Chemistry, Manufacturing & Controls
Bio-Rad
Blog
Cutting Edge Conversations: The Role of In Vivo Studies in Personalized Medicine
September 2, 2021
Read blog
Biomarkers
Disease Models
Pharmacology
No items found.
Market Access
No items found.
Biomarkers
HBS
Discovery Life Sciences
Protein Sciences
Antibodies
In Vitro Assays
R&D Systems
Pharmacology
Bhavika Patel
Morad Nakhleh
Natalie Smith
Lanterne Dx
Owlstone Medical
Eurofins Genomics
Scientist.com
Disease Models
Bioimaging
Matic Pusovnik
Geoff Warnock
Mette Lauritzen
Bruker Corporation
No items found.
Disease Models
In Vitro Assays
Cell Culture & Characterization
Agenor Limon
Harvard Bioscience, Inc.
No items found.
Disease Models
Pharmacology
Health Economics & Outcomes Research (HEOR)
James Marx
Kent Scientific Corporation
Academy of Surgical Research
Pharmacology
Cell Culture & Characterization
Clinical Trials
Danyi Wen
Shanghai LIDE Biotech Co., Ltd. (LIDE Biotech)
Scientist.com
Pharmacology
Disease Models
Andrea Bonetto
Aurora Scientific, Inc.
American Physiological Society
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Health Economics & Outcomes Research (HEOR)
Market Access
Real-World Evidence (RWE)
Pierre Etienne
Michael Pace
Clifton Chow
Actu-Real
HealthEconomics.com
Pharmacology
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
M.S.M. Mujeebur Rahuman
Holger von Moeller
Fernando Huerta
Aragen
MOLOX
Research Institutes of Sweden
Scientist.com
Disease Models
E. Dale Abel
No items found.
American Physiological Society
Alliance for Aging Research
Bioimaging
Chemical & Compound Analysis
Robert E. A. Williams
Mark Riccio
Thermo Fisher Scientific
No items found.
Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
.jpg)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.